
Evidence-Based Oncology Explores Benefits, Challenges of Alternate Payment Models in Cancer Care
As MACRA pushes physicians toward value-based reimbursement, how can the needs of cancer patients be served? The current issue of Evidence-Based Oncology,ââ€
FOR IMMEDIATE RELEASEApril 28, 2017
CRANBURY, N.J.—The revolution in how physicians will be paid brings unique challenges to cancer care, where individual patient needs may make costs hard to predict. As oncologists and payers adapt to this new environment, Evidence-Based Oncology™, (EBO™)a publication of The American Journal of Managed Care®, has
The traditional definition of value—costs over outcomes—cannot always incorporate the clinical and diagnostic risks that oncologists take in deciding how to proceed, writes
“Value has become a catchword in healthcare,” Alvarnas writes. “This has been true for a while already within the domain of cancer care, where the extraordinary complexity and intensity of effective care, coupled with the astronomical prices of new anticancer agents, have led many to question the economic sustainability of delivering effective and innovative care to this population of patients.”
In this special issue:
· Authors from
· Authors from the
· Jeffrey W. Chell, CEO of the
· Authors from
About The American Journal of Managed Care®:
The American Journal of Managed Care® (AJMC®) is a peer-reviewed, MEDLINE-indexed journal that keeps readers on the forefront of health policy by publishing research relevant to industry decision makers as they work to promote the efficient delivery of high-quality care.
Contacts:
AJMC® Media:
Theresa Burek
or
Surabhi Verma
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.